Analysis of Cancer Mutation Signatures in Blood by a Novel Ultra-Sensitive Assay: Monitoring of Therapy or Recurrence in Non-Metastatic Breast Cancer

Zhenbin Chen, Jinong Feng, Carolyn H. Buzin et al. · 2009

Read Analysis of Cancer Mutation Signatures in Blood by a Novel Ultra-Sensitive Assay: Monitoring of Therapy or Recurrence in Non-Metastatic Breast Cancer by Zhenbin Chen, Jinong Feng, Carolyn H. Buzin et al. (2009) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0007220.txt.

Description

Zhenbin Chen, Jinong Feng, Carolyn H. Buzin, and colleagues described an ultra-sensitive blood test for cancer mutations in 2009. Tumor DNA appears in circulating cells and as fragments in plasma. Finding very rare tumor mutations in blood could show whether therapy works or cancer has returned.

The authors focus on non-metastatic breast cancer, where tumor signals are faint. Their novel assay searches blood for cancer mutation signatures. Their PLOS ONE paper presents the method for monitoring therapy or recurrence. A reliable blood test could spare patients repeated tissue biopsies during follow-up care.

Catalog record

CREATORZhenbin Chen, Jinong Feng, Carolyn H. Buzin et al.
YEAR2009
COLLECTIONPAPERS
FORMATTXT
FILE SIZE65 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0007220

Browse the full library · About the Tower of Babel